A clinical trial to study the effects of of levetiracetam as a first line monotherapy in patients (>16 years) with partial seizures with or without secondary generalizatio

Phase 4

Completed

• Registration Number: CTRI/2011/091/000265
• Lead Sponsor: Abbott Healthcare Pvt Ltd

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 60

Inclusion Criteria

1.Patients of either sex with established diagnosis of partial seizures with or without secondary generalization.
2.Age above 16 years.
3.Newly diagnosed or treatment naïve epilepsy patients
4.Willing to give informed consent (for age above 16 years)
5.Women willing to use adequate contraceptive methods

Exclusion Criteria

1.Patients with seizures other than partial seizures with or without secondary generalization.
2.Patients with any progressive brain disease.
3.Patients with history of pre existing behavioral impairment
4.Patients with hepatic or renal impairment
5.Patients with severe obstructive respiratory disease
6.Patients with a clinically significant disorder which needs treatment.
7.Patients with acute intermittent porphyria
8.Patients currently on other antiepileptics
9.Patients on oral anticoagulants
10.Patients receiving corticosteroids
11.Patients receiving griseofulvin
12.Women who are pregnant or conceive during the study period

Study & Design

• Study Type: Interventional
• Study Design: Not specified